October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Cancer has a fearsome reputation.

It is a disease that has not yet fully yielded to the skills and intelligence of medical scientists and doctors.

And, as if the pain from the disease is not enough, the treatment for cancer, too, inflicts heavy suffering on the body.

Cancer is a disease characterized by uncontrolled and abnormal cell division.

Any Cancer can spread in the body and destroy tissues when the cancer cells travel through the bloodstream or the lymphatic system.

The runaway growth of cells is caused by mutations to the DNA in the cells that makes the cells unable to control cell division. This mutation can either be inherited or acquired.

The mortality rate in cancer depends on the type of cancer and where it originates or develops.

Among cancers, lung cancer is the biggest killer, causing up to 3 million deaths every year worldwide. It affects the above-50 age group population most.

The main risk factor for lung cancer is smoking. Cigarette smoke contains several carcinogens.

It is estimated that 80 percent of all lung cancers are caused by smoking. The role of passive smoking or second-hand smoke in causing lung cancer is also being recognized by studies.

Another carcinogen that causes lung cancer is asbestos. This substance, which is widely used because of its fire-resistant qualities, causes a rare type of cancer called mesothelioma cancer.

In mesothelioma asbestos lung cancer or asbestos cancer, malignant cells develop in the pleura, which is the outer lining of the lungs and the chest cavity.

The problem with asbestos cancer is that it is difficult to diagnose.

The symptoms of mesothelioma cancer occur only 30-50 years after the exposure to asbestos. Second, the symptoms of asbestos lung cancer, such as shortness of breath and chest pain, are similar to those of many other medical conditions.

The incidence of mesothelioma asbestos lung cancer has increased in the last two decades.

The most common lung cancer treatments include surgery, chemotherapy, and radiation therapy.

However, conventional treatment methods have not been very successful in the case of asbestos cancer.

However, there is hope for the cancer-affected. Scientists are developing new techniques for treatment. New drugs are being developed and tested.

Better and more effective therapies can be expected as scientists and researchers discover more secrets from the human cells.

Comments are closed.

Special Procedures

Click on Any Topic

Bone Marrow Transplants

Organ Transplants

Stem Cells

——————————————–

Euthanasia

Physician Assisted Suicide

Medical Topics
  • Long-Term Data Back Anti-PD-1 in Advanced Non-Squamous NSCLC
    (MedPage Today) -- Long-term data from an early first-line trial of pembrolizumab (Keytruda) plus chemotherapy showed that more than half of patients with advanced non-squamous non-small cell lung cancer (NSCLC) remained alive at 3 years. In cohort...
  • Suze Orman's Schwannoma
    (MedPage Today) -- Financial advisor, author and former CNBC host Suze Orman has always stressed that it is a mistake for people to ignore their money problems. Now she wants you to know that "the most vital and stupid mistake I could ever make...
  • 'License' to Smoke After Negative Lung Screening?
    (MedPage Today) -- Some individuals appear to interpret a negative low-dose CT (LDCT) lung screening scan as a green light to resume smoking, a post hoc analysis of the National Lung Screening Trial (NLST) found. For example, highly nicotine dependent...
  • Hunting Resistance Mechanisms in RET-Fusion Lung Cancer
    (MedPage Today) -- As detected by circulating tumor DNA (ctDNA), acquired resistance to pralsetinib (Gavreto) in RET fusion-positive lung cancer was relatively uncommon, findings from the ARROW study suggested. In 42 non-small cell lung cancer...
  • Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC
    (MedPage Today) -- A first-line immune checkpoint inhibitor combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) improved survival in patients with advanced non-small cell lung cancer (NSCLC) when added to a limited course of chemotherapy...
Content Protected Using Blog Protector By: PcDrome.